Clinical Trials Logo
  1. Home
  2. Primary Axillary Hyperhidrosis
  3. NCT03054480

Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis Clinical Trial

Official title:
A Comparative Study for Efficacy and Safety Between Fractional Micro-Needle Radiofrequency (FRM) and Intradermal Botulinum Toxin A for the Treatment of Primary Axillary Hyperhidrosis

Clinical Trial Summary

Because of the limiting data about an efficacy and safety of fractional radiofrequency for the treatment of hyperhidrosis, this study aim to compare clinical efficacy by Hyperhidrosis Disease Severity Score (HDSS) between Fractional Microneedle Radiofrequency device and intradermal Botulinum toxin type A injection for the treatment of primary axillary hyperhidrosis. The secondary objectives to determine the improvement change of iodine starch test, total amount of sweat production by trans-epidermal water loss (TEWL), patient's satisfaction and their quality of life by Dermatology Life Quality Index and side effect between the groups.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03054480
Study type Interventional
Source Mae Fah Luang University Hospital
Contact
Status Completed
Phase N/A
Start date August 1, 2016
Completion date January 31, 2017
View Details
See also
  Status Clinical Trial Phase
Completed NCT03627468 - A Safety Study of BBI-4000 Gel in Patients With Axillary Hyperhidrosis Phase 3
Completed NCT03658616 - Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. Phase 3
Completed NCT02286765 - Ulthera® System for Treating Axillary Hyperhidrosis N/A
Completed NCT04599907 - Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating N/A
Completed NCT03037788 - Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis Phase 1
Terminated NCT01722461 - A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis N/A
Completed NCT05863104 - Assessment of Safety, Tolerability, Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis Phase 2
Completed NCT02823340 - Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis N/A
Not yet recruiting NCT04159610 - Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis Phase 2
Completed NCT01799824 - Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis Phase 2
Completed NCT03785587 - A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis Phase 2